Stay updated on ARCHES: Enzalutamide in Metastatic Prostate Cancer Clinical Trial
Sign up to get notified when there's something new on the ARCHES: Enzalutamide in Metastatic Prostate Cancer Clinical Trial page.

Latest updates to the ARCHES: Enzalutamide in Metastatic Prostate Cancer Clinical Trial page
- Check2 days agoChange DetectedThe ClinicalTrials.gov site footer revision label changed from v3.7.0 to v3.7.1.SummaryDifference0.0%

- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedA new revision entry v3.7.0 was added to the study record history, replacing the previous revision v3.6.6. This reflects an updated version of the record in the history log.SummaryDifference0.0%

- Check44 days agoChange DetectedA new revision entry, v3.6.6, was added to the study's history and the prior revision v3.6.5 was removed, updating the record timeline. This update relates to historical record maintenance rather than substantive changes to the trial content.SummaryDifference0.0%

- Check65 days agoChange DetectedAdded a new revision marker 'Revision: v3.6.5' to the study record history. The older 'Revision: v3.6.4' entry and the 'References' section were removed.SummaryDifference0.1%

- Check79 days agoChange DetectedRevision: v3.6.4 was added to the history list, replacing Revision: v3.6.3, indicating a small update to the page's UI/backend.SummaryDifference0.0%

- Check101 days agoChange DetectedRevision: v3.6.3 was added in place of Revision: v3.6.2 in the page footer, indicating a deployment update to the site's software. The update does not change visible content.SummaryDifference0.0%

Stay in the know with updates to ARCHES: Enzalutamide in Metastatic Prostate Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ARCHES: Enzalutamide in Metastatic Prostate Cancer Clinical Trial page.